" "

Today, protecting against risk in the operating room and beyond is a priority.

The SARS-CoV-2 pandemic is an unprecedented health care event with consequences that ripple across the continuum of care. This ripple effect can cause further disruption and directly impact access to care, quality of care, and cost of care.

  • Prevena product image

    Postoperative complications can increase the need for “high-touch care.”

    Postoperative complications are a challenge to hospitals needing to free up capacity in hospital and intensive care unit (ICU) beds.1 High-touch care can also result in a greater number of person-to-person exposures.

    The power of PREVENA™ Therapy: Protecting beyond the OR to help stop the postoperative ripple effect.

    By helping to protect incisions from postoperative complications, PREVENA™ Therapy works to help stop the ripple effect before it begins, protecting patients, surgeons, staff, practices, and hospitals from potential consequences through lowtouch care that strives to1,2:

    • Enable rapid discharge with portable design
    • Help reduce postoperative surgical site complications*
    • Help minimize patient exposure to the health care facility

    Learn more

    To learn more, download one of these PREVENA™ Therapy Specialty brochures:

    Orthopedic Brochure

    Plastic Surgery Brochure

    CT/Vascular Brochure

Stop the Ripple Effect

Now, more than ever, protecting patients, clinicians, practices, and hospitals is of great importance. To request a complimentary PREVENA™ Therapy product evaluation, fill out the form below:

  • All fields are required unless indicated optional

  • 3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit

  • *PREVENA™ 125 and PREVENA PLUS™ 125 Therapy Units manage the environment of closed surgical incisions and remove fluid away from the surgical incision via the application of -125mmHg continuous negative pressure. When used with legally marketed compatible dressings, PREVENA™ 125 and PREVENA PLUS™ 125 Therapy Units are intended to aid in reducing the incidence of seroma; and in patients at high risk for post-operative infections, aid in reducing the incidence of superficial surgical site infection in Class I and Class II wounds.

    The effectiveness of PREVENA™ Therapy in reducing the incidence of SSIs and seroma in all surgical procedures and populations has not been demonstrated. See full indications for use and limitations at myKCI.com.


    1. Parvizi J, Gehrke T, Krueger CA, et al. Resuming Elective Orthopaedic Surgery During the COVID-19 Pandemic: Guidelines Developed by the International Consensus Group (ICM) [published online ahead of print, 2020 May 14]. J Bone Joint Surg Am. 2020;10.2106/JBJS.20.00844
    2. Banasiewicz T, Becker R, Bobkiewicz, A, et. al. Prevention and therapy of acute and chronic wounds using NPWT devices during the COVID-19 pandemic, recommendation from The NPWT Working Group. Negative Pressure Wound Therapy Journal. 2020;7(2).

NOTE: Specific indications, limitations, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician andproduct instructions for use prior to application. Rx only.

PRA-PM-US-02636 (7/20)

The brands listed above are trademarks of 3M.

United States - English